TLX (TLX) Stock Price & Analysis
TLX (TLX) rose 0.34% to USD 11.98 as of September 9, 2026 at 00:10 UTC, according to Nexqual real-time market data.
TLX last closed at USD 11.98; the session ranged USD 11.98–12.21 on volume of 335,606 shares. Market capitalization is —, with a 52-week range of USD 6.28–12.48 (NMS). Source: Nexqual, September 9, 2026 at 00:10 UTC.
Key Statistics (as of September 9, 2026 at 00:10 UTC)
| Price | USD 11.98 |
|---|---|
| Change | ▲ 0.34% (up) |
| Previous Close | USD 11.98 |
| Open | USD 11.98 |
| Day Range | USD 11.98 – 12.21 |
| 52-Week Range | USD 6.28 – 12.48 |
| Volume | 335,606 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (TLX)
Nexqual's technical model rates TLX "STRONG BUY" based on 5 bullish and 0 bearish signals across 126 daily candles, as of September 9, 2026 at 00:10 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 56.44 (neutral) |
| vs SMA50 | Above (USD 11.19) |
| MACD | 0.14 (positive) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MLYS | Mineralys Therapeutics, Inc. | USD 31.12 | ▲ 10.08% |
| SYRE | Spyre Therapeutics, Inc. | USD 90.79 | ▲ 4.06% |
| CGON | CG Oncology, Inc. | USD 73.4 | ▼ 1.25% |
| ALMS | Alumis Inc. | USD 10.58 | ▼ 6.87% |
| ABVX | Abivax SA | USD 118.95 | ▲ 4.31% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 9, 2026 at 00:10 UTC. This page is informational and not investment advice.